Myriad Genetics, Inc. (MYGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Myriad Genetics, Inc. (MYGN)

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
2355	65	0	MYGN

Emcee: s myers	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1230	I listened to the CC last night and again this a.m. After 1st listen, I felt th	zeta1961	-	5/3/2005
1229	going to be an interesting last hour of trading. as you watch it, wonder where	scaram(o)uche	-	5/3/2005
1228	Top line results were presented in a strange fashion. If they'd have said t	scaram(o)uche	-	5/3/2005
1227	Can you explain to me why the huge concern with what the moderate group stats we	LJM	-	5/3/2005
1226	under normal circumstances, fund managers would be buying -- like crazy and righ	scaram(o)uche	-	5/3/2005
1225	>> This one is as easy a decision as they get. Just my two cents. <<	scaram(o)uche	-	5/3/2005
1224	Is there a csfb analysis on SI?	keokalani'nui	-	5/3/2005
1223	<How does anyone diagnose onset/mild ad at this point?> This question was	Zirdu	-	5/3/2005
1222	Very bad cc. Meldrum said mild, moderate AD, doses level are prespecified group	Lee39	-	5/3/2005
1221	I've already given my opinion..... the CSFB analysis is just plain bad. B	scaram(o)uche	-	5/3/2005
1220	I agree with your thoughts....but? How does anyone diagnose onset/mild ad at th	LJM	-	5/3/2005
1219	I have been thinking about this situation very hard for last 18 hours. The CS	Robohogs	-	5/3/2005
1218	Meldrum wouldn't give a clear answer asto whether F is beneficial to moderat	Lee39	-	5/2/2005
1217	Rick, if the results for the mild hold up in Phase III, and the drug makes it to	Jim Haynes	-	5/2/2005
1216	I see what you mean. I was offline for an earlier Q&A that makes that last	scaram(o)uche	-	5/2/2005
1215	groan.... by now, you know the answer to your question. ;-) ;-(	scaram(o)uche	-	5/2/2005
1214	OK, that means something to me....for now. But a lot of people who didn't m	keokalani'nui	-	5/2/2005
1213	>> That was a pretty bad Q&A in my opinion, and the company looks like	scaram(o)uche	-	5/2/2005
1212	will listen again, once it's archived, to see if there were any important bi	scaram(o)uche	-	5/2/2005
1211	Placebo patients declined slower than historical controls. Two sites of 31 excl	scaram(o)uche	-	5/2/2005
1210	Did you notice how a couple of the questioners kept pressing the question about	atticus4paws	-	5/2/2005
1209	I think Meldrum must be hard of hearing. That was a pretty bad Q&A in my o	keokalani'nui	-	5/2/2005
1208	duplicate post, don't know how that happened. sorry.	scaram(o)uche	-	5/2/2005
1207	I couldn't believe that the company kept going, even through the introductio	scaram(o)uche	-	5/2/2005
1206	Primary goal of ph 2 is finding the appropriate dose, beside checking for safety	Lee39	-	5/2/2005

Go to reply# or date (mm/dd/yy):